logo

COCH

Envoy Medical·NASDAQ
--
--(--)
--
--(--)

COCH fundamentals

Envoy Medical (COCH) released its earnings on Nov 10, 2025: revenue was 42.00K (YoY -25.00%), missed estimates; EPS was -0.35 (YoY +5.41%), missed estimates.
Revenue / YoY
42.00K
-25.00%
EPS / YoY
-0.35
+5.41%
Report date
Nov 10, 2025
EPS
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
0.13-0.3-0.32-0.27-0.37-0.53-0.29-0.32-0.35
Forecast
0.13-0.19-0.225-0.2525-0.2725-0.3133-0.3575-0.3025-0.24
Surprise
0.00%
-57.89%
-42.22%
-6.93%
-35.78%
-69.17%
+18.88%
-5.79%
-45.83%
Revenue
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Actual
80.00K95.00K59.00K68.00K56.00K42.00K46.00K78.00K42.00K
Forecast
--75.00K87.50K82.50K75.00K86.67K65.00K66.25K60.00K
Surprise
0.00%
+26.67%
-32.57%
-17.58%
-25.33%
-51.54%
-29.23%
+17.74%
-30.00%

Earnings Call